| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.09 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |